Song Christopher I, Pogson Jacob M, Andresen Nicholas S, Ward Bryan K
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Front Neurol. 2021 May 20;12:662264. doi: 10.3389/fneur.2021.662264. eCollection 2021.
Capillaries within the inner ear form a semi-permeable barrier called the blood-labyrinth barrier that is less permeable than capillary barriers elsewhere within the human body. Dysfunction of the blood-labyrinth barrier has been proposed as a mechanism for several audio-vestibular disorders. There has been interest in using magnetic resonance imaging (MRI) with intravenous gadolinium-based contrast agents (GBCA) as a marker for the integrity of the blood labyrinth barrier in research and clinical settings. This scoping review evaluates the evidence for using intravenous gadolinium-enhanced MRI to assess the permeability of the blood-labyrinth barrier in healthy and diseased ears. A systematic search was conducted of three databases: PubMed, EMBASE, CINAHL PLUS. Studies were included that used GBCA to study the inner ear and permeability of the blood-labyrinth barrier. Data was collected on MRI protocols used and inner ear enhancement patterns of healthy and diseased ears in both human and animal studies. The search yielded 14 studies in animals and 53 studies in humans. In healthy animal and human inner ears, contrast-enhanced MRI demonstrated gradual increase in inner ear signal intensity over time that was limited to the perilymph. Signal intensity peaked at 100 min in rodents and 4 h in humans. Compared to controls, patients with idiopathic sudden sensorineural hearing loss and otosclerosis had increased signal intensity both before and shortly after GBCA injection. In patients with Ménière's disease and vestibular schwannoma, studies reported increased signal at 4 h, compared to controls. Quality assessment of included studies determined that all the studies lacked sample size justification and many lacked adequate control groups or blinded assessors of MRI. The included studies provided convincing evidence that gadolinium crosses the blood-labyrinth barrier in healthy ears and more rapidly in some diseased ears. The timing of increased signal differs by disease. There was a lack of evidence that these findings indicate general permeability of the blood-labyrinth barrier. Future studies with consistent and rigorous methods are needed to investigate the relationship between gadolinium uptake and assessments of inner ear function and to better determine whether signal enhancement indicates permeability for molecules other than gadolinium.
内耳中的毛细血管形成了一种称为血迷路屏障的半透性屏障,其通透性低于人体其他部位的毛细血管屏障。血迷路屏障功能障碍已被提出是几种听觉前庭疾病的发病机制。在研究和临床环境中,人们一直对使用静脉注射钆基造影剂(GBCA)的磁共振成像(MRI)作为血迷路屏障完整性的标志物感兴趣。本综述评估了使用静脉注射钆增强MRI评估健康和患病耳朵血迷路屏障通透性的证据。对三个数据库进行了系统检索:PubMed、EMBASE、CINAHL PLUS。纳入的研究使用GBCA研究内耳和血迷路屏障的通透性。收集了关于所使用的MRI方案以及人类和动物研究中健康和患病耳朵的内耳强化模式的数据。检索结果为14项动物研究和53项人类研究。在健康的动物和人类内耳中,对比增强MRI显示内耳信号强度随时间逐渐增加,且仅限于外淋巴。信号强度在啮齿动物中在100分钟时达到峰值,在人类中在4小时时达到峰值。与对照组相比,特发性突发性感音神经性听力损失和耳硬化症患者在注射GBCA之前和之后不久信号强度均增加。在梅尼埃病和前庭神经鞘瘤患者中,研究报告与对照组相比,4小时时信号增加。纳入研究的质量评估确定,所有研究均缺乏样本量合理性说明,许多研究缺乏适当的对照组或MRI的盲法评估者。纳入的研究提供了令人信服的证据,表明钆在健康耳朵中穿过血迷路屏障,在一些患病耳朵中穿过得更快。信号增加的时间因疾病而异。缺乏证据表明这些发现表明血迷路屏障的一般通透性。需要采用一致且严格的方法进行未来研究,以调查钆摄取与内耳功能评估之间的关系,并更好地确定信号增强是否表明除钆之外的分子的通透性。